Concepedia

Minal Barve

MB

Statistics

Publications

80

Citations

6.8K

H-Index

33

Active since

2007

Affiliations

Mary Crowley Cancer Research Center(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Texas Oncology

Minal Barve is an author at Mary Crowley Cancer Research Center specializing in medicine, oncology, and pharmacology.

Publications per year

2007–2025

80

Publications

80

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele, Alexander Drilon, Luis Paz‐Ares et al. · The Lancet Oncology · 2019 · 1.7K citations · Full text

Medicine, Oncology, Metastasis +9

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C

Rona Yaeger, Jared Weiss, Meredith Pelster et al. · New England Journal of Medicine · 2022 · 485 citations · Full text

Medicine, Oncology, Pharmacology +16

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 454 citations · Full text

Medicine, Oncology, Pharmacology +12

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar et al. · Cancer Discovery · 2018 · 341 citations · Full text

Medicine, Immunology, Oncology +17

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced <i>KRAS</i><sup><i>G12C</i></sup> Solid Tumors (KRYSTAL-1)

Sai‐Hong Ignatius Ou, Pasi A. Jänne, Ticiana Leal et al. · Journal of Clinical Oncology · 2022 · 300 citations · Full text

Pharmacy, Oncology, Pharmacology +16

1–5 of 80